Exelixis

Exelixis reports 1st-quarter loss, misses expectations
Yahoo/AP
Wed, 05/4/16 - 06:45 pm
Exelixis
earnings
Exelixis reports fourth-quarter loss but tops expectations
Yahoo/AP
Mon, 02/29/16 - 11:57 pm
Exelixis
earnings
Exelixis Rises on Positive Late-Stage Trial Results
24/7 Wall St
Mon, 02/1/16 - 11:17 pm
Exelixis
cabozantinib
renal cell carcinoma
clinical trials
The Top 5 Best Performing Biotech Stocks of 2015
Motley Fool
Sat, 01/2/16 - 10:27 am
biotech
Eagle Pharmaceuticals
Exelixis
Prothena
Anacor
Heron Therapeutics
The Best Biotech Stocks in 2015
Motley Fool
Mon, 12/28/15 - 09:58 am
Eagle Pharmaceuticals
Exelixis
Prothena
[video]2 Healthcare Stocks That Dominated in 2015
Motley Fool
Mon, 12/28/15 - 09:50 am
Portola Pharmaceuticals
Exelixis
3 Biotech Stocks Under $5 That Could Explode Higher in 2016
Motley Fool
Sun, 12/27/15 - 10:28 am
Geron
Agenus
Exelixis
The FDA Approves Exelixis, Inc's New Cancer Drug
Motley Fool
Mon, 11/23/15 - 10:05 am
FDA
Exelixis
Cotellic
melanoma
Exelixis Announces Presentation of Positive Overall Survival Results for COTELLIC™ in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma at Society for Melanoma Research 2015 International Congress
Yahoo
Sun, 11/22/15 - 10:49 am
Exelixis
Cotellic
melanoma
Exelixis, Inc. Earnings: Riding the Meteor
Motley Fool
Mon, 11/16/15 - 11:50 am
earnings
Exelixis
Genentech, Exelixis score another PhIII success for cobimetinib
Fierce Biotech
Tue, 10/6/15 - 09:59 am
Genentech
Exelixis
Cobimetinib
melanoma
BRAF V600
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
Cometriq Plays Wallflower As Opdivo's Dance Card Fills
Seeking Alpha
Mon, 09/28/15 - 08:23 am
Bristol-Myers Squibb
Opdivo
Cometriq
Exelixis
kidney cancer
We Believe Healthcare's Next Biotech Buyout Target Is…
Motley Fool
Sun, 08/30/15 - 02:05 pm
M&A
Biocryst
Biogen
Exelixis
FDA Grants Breakthrough Therapy Designation to Exelixis’ Cabozantinib for the Treatment of Renal Cell Carcinoma in Patients Who Received One Prior Therapy
Yahoo
Mon, 08/24/15 - 11:26 am
FDA
Exelixis
breakthrough therapies
renal cell carcinoma
cabozantinib
Exelixis reports 2Q loss
Yahoo/AP
Tue, 08/11/15 - 06:55 pm
earnings
Exelixis
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
3 Biotech Stocks That Could Double Before 2016
Motley Fool
Sun, 07/26/15 - 08:45 pm
Exelixis
Spark Therapeutics
Geron
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb

Pages